Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited (PANHF) Financial Performance & Income Statement Overview
Explore the financials of Ping An Healthcare and Technology Company Limited (PANHF), including yearly and quarterly data on income, cash flow, and balance sheets.
Ping An Healthcare and Technology Company Limited (PANHF) Income Statement & Financial Overview
Analyze Ping An Healthcare and Technology Company Limited’s PANHF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.71B | $2.09B | $2.45B | $2.22B |
| Cost of Revenue | $1.87B | $1.42B | $1.66B | $1.51B |
| Gross Profit | $849.56M | $673.80M | $793.15M | $715.36M |
| Gross Profit Ratio | $0.31 | $0.32 | $0.32 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $932.15M | $761.34M | $1.11B | $1.21B |
| Operating Expenses | $897.11M | $715.31M | $1.01B | $1.10B |
| Total Costs & Expenses | $2.76B | $2.13B | $2.67B | $2.61B |
| Interest Income | $185.96M | $0.00 | $135.22M | $140.53M |
| Interest Expense | $3.40M | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $75.66M | $20.60M | $29.07M | $35.89M |
| EBITDA | $248.63M | -$55.21M | -$201.44M | -$418.22M |
| EBITDA Ratio | $0.09 | -$0.03 | -$0.08 | -$0.19 |
| Operating Income | -$47.55M | -$41.52M | -$218.17M | -$454.11M |
| Operating Income Ratio | -$0.02 | -$0.02 | -$0.09 | -$0.20 |
| Other Income/Expenses (Net) | $80.67M | $102.17M | $130.54M | $112.83M |
| Income Before Tax | $33.12M | $60.65M | -$87.63M | -$244.26M |
| Income Before Tax Ratio | $0.01 | $0.03 | -$0.04 | -$0.11 |
| Income Tax Expense | $5.43M | $23000.00 | $2.36M | $604000.00 |
| Net Income | $24.78M | $56.65M | -$77.98M | -$244.62M |
| Net Income Ratio | $0.009 | $0.03 | -$0.03 | -$0.11 |
| EPS | $0.02 | $0.05 | -$0.07 | -$0.23 |
| Diluted EPS | $0.02 | $0.05 | -$0.07 | -$0.23 |
| Weighted Avg Shares Outstanding | $1.13B | $1.13B | $1.08B | $1.06B |
| Weighted Avg Shares Outstanding (Diluted) | $1.08B | $1.08B | $1.08B | $1.08B |
Over the past four quarters, Ping An Healthcare and Technology Company Limited demonstrated steady revenue growth, increasing from $2.22B in Q2 2023 to $2.71B in Q4 2024. Operating income reached -$47.55M in Q4 2024, maintaining a consistent -2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $248.63M, reflecting operational efficiency. Net income dropped to $24.78M, with EPS at $0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan